{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:35:39Z","timestamp":1770813339324,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.nutres.2025.12.005","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:48:04Z","timestamp":1765903684000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Moderate dietary intake of omega-3 polyunsaturated fatty acids is associated with reduced all-cause mortality in metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"146","author":[{"given":"Ye","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanni","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0370-4989","authenticated-orcid":false,"given":"Chunhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nutres.2025.12.005_bib0001","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol."},{"key":"10.1016\/j.nutres.2025.12.005_bib0002","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet."},{"key":"10.1016\/j.nutres.2025.12.005_bib0003","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.cgh.2025.02.006","article-title":"High global prevalence of steatotic liver disease and associated subtypes: a meta-analysis","volume":"23","author":"Ho","year":"2025","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.nutres.2025.12.005_bib0004","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology."},{"key":"10.1016\/j.nutres.2025.12.005_bib0005","doi-asserted-by":"crossref","first-page":"e0251","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol Commun."},{"key":"10.1016\/j.nutres.2025.12.005_bib0006","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jhep.2025.03.001","article-title":"Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden","volume":"83","author":"Issa","year":"2025","journal-title":"J Hepatol."},{"key":"10.1016\/j.nutres.2025.12.005_bib0007","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10.1016\/j.nutres.2025.12.005_bib0008","first-page":"1777","article-title":"Impact of metabolic dysfunction-associated steatotic liver disease on cardiovascular structure, function, and the risk of heart failure","volume":"41","author":"Bansal","year":"2025","journal-title":"Can J Cardiol."},{"key":"10.1016\/j.nutres.2025.12.005_bib0009","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001058","article-title":"A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease","author":"Ivancovsky Wajcman","year":"2024","journal-title":"Hepatology."},{"key":"10.1016\/j.nutres.2025.12.005_bib0010","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep4.1906","article-title":"Effect of omega-3 polyunsaturated fatty acids on lipid metabolism in patients with metabolic syndrome and NAFLD","volume":"6","author":"\u0160m\u00edd","year":"2022","journal-title":"Hepatol Commun."},{"key":"10.1016\/j.nutres.2025.12.005_bib0011","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.3390\/nu12113372","article-title":"Impact of long-term supplementation with fish oil in individuals with non-alcoholic fatty liver disease: a double blind randomized placebo controlled clinical trial","volume":"12","author":"Cansan\u00e7\u00e3o","year":"2020","journal-title":"Nutrients."},{"key":"10.1016\/j.nutres.2025.12.005_bib0012","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/1440-1681.13750","article-title":"Omega-3 polyunsaturated fatty acids in the treatment of non-alcoholic fatty liver disease: an umbrella systematic review and meta-analysis","volume":"50","author":"Musazadeh","year":"2023","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"10.1016\/j.nutres.2025.12.005_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101255","article-title":"Omega-3 long-chain polyunsaturated fatty acids: metabolism and health implications","volume":"92","author":"Khan","year":"2023","journal-title":"Prog Lipid Res."},{"key":"10.1016\/j.nutres.2025.12.005_bib0014","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-food-111317-095850","article-title":"Omega-3 polyunsaturated fatty acids and their health benefits","volume":"9","author":"Shahidi","year":"2018","journal-title":"Annu Rev Food Sci Technol."},{"key":"10.1016\/j.nutres.2025.12.005_bib0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clnu.2025.05.013","article-title":"Omega-3 polyunsaturated fatty acids and nonalcoholic fatty liver disease in adults: a meta-analysis of randomized controlled trials","volume":"50","author":"Kim","year":"2025","journal-title":"Clin Nutr."},{"key":"10.1016\/j.nutres.2025.12.005_bib0016","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-nutr-061021-030223","article-title":"Nonalcoholic fatty liver disease and omega-3 fatty acids: mechanisms and clinical use","volume":"43","author":"Spooner","year":"2023","journal-title":"Annu Rev Nutr."},{"issue":"9","key":"10.1016\/j.nutres.2025.12.005_bib0017","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/nu12092769","article-title":"Effects of omega-3 polyunsaturated fatty acid supplementation on non-alcoholic fatty liver: a systematic review and meta-analysis","volume":"12","author":"Lee","year":"2020","journal-title":"Nutrients."},{"key":"10.1016\/j.nutres.2025.12.005_bib0018","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3390\/nu17101657","article-title":"Nutraceutical strategies for metabolic dysfunction-associated steatotic liver disease (MASLD): a path to liver health","volume":"17","author":"Vrentzos","year":"2025","journal-title":"Nutrients."},{"key":"10.1016\/j.nutres.2025.12.005_bib0019","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey","volume":"41","author":"Ruhl","year":"2014","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.nutres.2025.12.005_bib0020","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jand.2018.05.021","article-title":"Update of the healthy eating index: HEI-2015","volume":"118","author":"Krebs-Smith","year":"2018","journal-title":"J Acad Nutr Diet."},{"key":"10.1016\/j.nutres.2025.12.005_bib0021","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ajcnut.2024.08.021","article-title":"Dietaryindex: a user-friendly and versatile R package for standardizing dietary pattern analysis in epidemiological and clinical studies","volume":"120","author":"Zhan","year":"2024","journal-title":"Am J Clin Nutr."},{"key":"10.1016\/j.nutres.2025.12.005_bib0022","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.clnu.2017.08.031","article-title":"Omega-3 PUFA modulate lipogenesis, ER stress, and mitochondrial dysfunction markers in NASH - proteomic and lipidomic insight","volume":"37","author":"Okada","year":"2018","journal-title":"Clin Nutr."},{"key":"10.1016\/j.nutres.2025.12.005_bib0023","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1053\/j.gastro.2012.02.018","article-title":"Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma","volume":"142","author":"Sawada","year":"2012","journal-title":"Gastroenterology."},{"key":"10.1016\/j.nutres.2025.12.005_bib0024","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1080\/10408398.2018.1544542","article-title":"N-3 polyunsaturated fatty acids for the management of alcoholic liver disease: a critical review","volume":"59","author":"Wang","year":"2018","journal-title":"Crit Rev Food Sci Nutr."},{"key":"10.1016\/j.nutres.2025.12.005_bib0025","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell."},{"key":"10.1016\/j.nutres.2025.12.005_bib0026","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease \u2013 novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J Hepatol."},{"key":"10.1016\/j.nutres.2025.12.005_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077090","article-title":"Advances in the understanding and management of alcohol-related liver disease","volume":"383","author":"Thursz","year":"2023","journal-title":"BMJ."},{"key":"10.1016\/j.nutres.2025.12.005_bib0028","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.tips.2018.01.003","article-title":"Specialized proresolving mediators: enhancing nonalcoholic steatohepatitis and fibrosis resolution","volume":"39","author":"Musso","year":"2018","journal-title":"Trends Pharmacol Sci."},{"key":"10.1016\/j.nutres.2025.12.005_bib0029","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.nutres.2025.12.005_bib0030","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology."},{"key":"10.1016\/j.nutres.2025.12.005_bib0031","article-title":"Dietary \u03b1-linolenic acid-rich flaxseed oil prevents against alcoholic hepatic steatosis via ameliorating lipid homeostasis at adipose tissue-liver axis in mice","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep."},{"key":"10.1016\/j.nutres.2025.12.005_bib0032","first-page":"1529","article-title":"Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression","volume":"38","author":"Sekiya","year":"2003","journal-title":"Hepatology."},{"key":"10.1016\/j.nutres.2025.12.005_bib0033","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000871","article-title":"Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism","volume":"8","author":"Green","year":"2020","journal-title":"BMJ Open Diabetes Res Care."},{"key":"10.1016\/j.nutres.2025.12.005_bib0034","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jhep.2008.04.023","article-title":"Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids","volume":"49","author":"Song","year":"2008","journal-title":"J Hepatol."},{"key":"10.1016\/j.nutres.2025.12.005_bib0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/biof.1246","article-title":"Endogenously elevated n-3 polyunsaturated fatty acids alleviate acute ethanol-induced liver steatosis","volume":"41","author":"Huang","year":"2015","journal-title":"Biofactors"},{"key":"10.1016\/j.nutres.2025.12.005_bib0036","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12944-017-0431-8","article-title":"Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice","volume":"16","author":"Zhang","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.nutres.2025.12.005_bib0037","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.3390\/ijms21093066","article-title":"The molecular and mechanistic insights based on gut-liver axis: nutritional target for non-alcoholic fatty liver disease (NAFLD) improvement","volume":"21","author":"Ji","year":"2020","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.nutres.2025.12.005_bib0038","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.mayocp.2021.03.004","article-title":"Omega-3 benefits remain strong post-STRENGTH","volume":"96","author":"Bernasconi","year":"2021","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.nutres.2025.12.005_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114864","article-title":"Effects of flaxseed powder in improving non-alcoholic fatty liver by regulating gut microbiota-bile acids metabolic pathway through FXR\/TGR5 mediating","volume":"163","author":"Yang","year":"2023","journal-title":"Biomed Pharmacother."},{"key":"10.1016\/j.nutres.2025.12.005_bib0040","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/ptr.6972","article-title":"Effect of portulaca oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: a randomized, double-blind clinical trial","volume":"35","author":"Darvish Damavandi","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.nutres.2025.12.005_bib0041","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1007\/s11357-025-01512-0","article-title":"Dietary flaxseed: cardiometabolic benefits and its role in promoting healthy aging","volume":"47","author":"Kunutsor","year":"2025","journal-title":"Geroscience."},{"key":"10.1016\/j.nutres.2025.12.005_bib0042","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jhep.2007.09.009","article-title":"Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study","volume":"48","author":"Allard","year":"2007","journal-title":"J Hepatol."},{"key":"10.1016\/j.nutres.2025.12.005_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173376","article-title":"Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-\/- mice","volume":"12","author":"Lytle","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.nutres.2025.12.005_bib0044","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ejcn.2017.9","article-title":"Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study","volume":"71","author":"Hodson","year":"2017","journal-title":"Eur J Clin Nutr."},{"key":"10.1016\/j.nutres.2025.12.005_bib0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/nutrit\/nuy022","article-title":"Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease","volume":"76","author":"Musa-Veloso","year":"2018","journal-title":"Nutr Rev."},{"key":"10.1016\/j.nutres.2025.12.005_bib0046","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/metabo9110252","article-title":"A lipidomic analysis of docosahexaenoic acid (22:6, \u03c93) mediated attenuation of western diet induced nonalcoholic steatohepatitis in male Ldlr -\/- mice","volume":"9","author":"Garc\u00eda-Jaramillo","year":"2019","journal-title":"Metabolites."},{"key":"10.1016\/j.nutres.2025.12.005_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101165","article-title":"Polyunsaturated fatty acids and fatty acid-derived lipid mediators: recent advances in the understanding of their biosynthesis, structures, and functions","volume":"86","author":"Dyall","year":"2022","journal-title":"Prog Lipid Res."},{"key":"10.1016\/j.nutres.2025.12.005_bib0048","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3945\/jn.112.171322","article-title":"Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-\/-) mouse model of western diet-induced nonalcoholic steatohepatitis","volume":"143","author":"Depner","year":"2013","journal-title":"J Nutr."},{"key":"10.1016\/j.nutres.2025.12.005_bib0049","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.mayocp.2020.08.034","article-title":"Effect of omega-3 dosage on cardiovascular outcomes: an updated meta-analysis and meta-regression of interventional trials","volume":"96","author":"Bernasconi","year":"2020","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.nutres.2025.12.005_bib0050","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.296.15.1885","article-title":"Fish intake, contaminants, and human health: evaluating the risks and the benefits","volume":"296","author":"Mozaffarian","year":"2006","journal-title":"JAMA."},{"key":"10.1016\/j.nutres.2025.12.005_bib0051","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.dld.2007.10.003","article-title":"Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease","volume":"40","author":"Spadaro","year":"2008","journal-title":"Dig Liver Dis."},{"key":"10.1016\/j.nutres.2025.12.005_bib0052","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.advnut.2023.08.003","article-title":"Safety of supplementation of omega-3 polyunsaturated fatty acids: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Chang","year":"2023","journal-title":"Adv Nutr."},{"key":"10.1016\/j.nutres.2025.12.005_bib0053","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.025071","article-title":"Omega-3 polyunsaturated fatty acids intake and blood pressure: a dose-response meta-analysis of randomized controlled trials","volume":"11","author":"Zhang","year":"2022","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.nutres.2025.12.005_bib0054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2013.03.010","article-title":"Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot","volume":"89","author":"Schuchardt","year":"2013","journal-title":"Essent Fatty Acids."},{"key":"10.1016\/j.nutres.2025.12.005_bib0055","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1038\/s41467-023-37702-7","article-title":"Lipid flipping in the omega-3 fatty-acid transporter","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat Commun."},{"key":"10.1016\/j.nutres.2025.12.005_bib0056","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417261","article-title":"Differential interventional effects of omega-6 and omega-3 polyunsaturated fatty acids on high fat diet-induced obesity and hepatic pathology","volume":"24","author":"Hao","year":"2023","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.nutres.2025.12.005_bib0057","doi-asserted-by":"crossref","first-page":"1467S","DOI":"10.1093\/ajcn\/83.6.1467S","article-title":"Distribution, interconversion, and dose response of n-3 fatty acids in humans","volume":"83","author":"Arterburn","year":"2006","journal-title":"Am J Clin Nutr."},{"key":"10.1016\/j.nutres.2025.12.005_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2022.102441","article-title":"Influence of the nutritional status and oxidative stress in the desaturation and elongation of n-3 and n-6 polyunsaturated fatty acids: Impact on non-alcoholic fatty liver disease. Prostaglandins Leukot","volume":"181","author":"Videla","year":"2022","journal-title":"Essent Fatty Acids."}],"container-title":["Nutrition Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531725001551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531725001551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:24:15Z","timestamp":1770794655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0271531725001551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":58,"alternative-id":["S0271531725001551"],"URL":"https:\/\/doi.org\/10.1016\/j.nutres.2025.12.005","relation":{},"ISSN":["0271-5317"],"issn-type":[{"value":"0271-5317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moderate dietary intake of omega-3 polyunsaturated fatty acids is associated with reduced all-cause mortality in metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Nutrition Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nutres.2025.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}